<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02948790</url>
  </required_header>
  <id_info>
    <org_study_id>PIC_05</org_study_id>
    <nct_id>NCT02948790</nct_id>
  </id_info>
  <brief_title>Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma</brief_title>
  <acronym>NeuriStim</acronym>
  <official_title>Auditory Nerve Monitoring Using Intra-cochlear Stimulation in Subjects With Acoustic Neuroma : Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oticon Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oticon Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the auditory nerve functionality with an intraoperative
      approach following a surgical removal of acoustic neuroma in patients with severe to profound
      sensorineural hearing disabilities.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Whatever the acoustic neuroma treatments, the patient risks a hearing loss. The global
      strategy of hearing care aims to preserve the quality of life and patient hearing. For severe
      to profound hearing loss and anatomical auditory nerve preservation, the cochlear implant is
      put forward compared to the auditory brainstem implant. Indeed, cochlear implant provides
      better speech outcomes. If cochlear implantation is not possible or no benefit for the
      patient, the brainstem implant is the most widely used. The Neuristim device is used to
      investigate the auditory nerve integrity following neuroma surgery or on an affected auditory
      nerve. The Neuristim is an intra-cochlear stimulator used in an intraoperative way. The
      intra-cochlear electrodes provide an electrical stimulation to auditory nerve fibers, and
      auditory nerve response measurements to these electrical stimulation are recorded and
      evaluated to determine the auditory nerve functionality. The Neuristim is a device for
      helping surgeons to choose the most appropriate implantable solution. 2 groups of patients
      will be involved in this study:

        -  a group of 17 patients with an acoustic neuroma or a past neuroma surgically removed or
           acoustic neuroma not requiring a surgery and with severe to profound hearing loss
           candidate for a cochlear implant or a auditory brainstem depending on the auditory nerve
           functionality,

        -  a group of 17 patients with severe to profound hearing loss candidate for a cochlear
           implant.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2017</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wave V latency</measure>
    <time_frame>perioperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>perioperatively, 15 days postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impedance measurement</measure>
    <time_frame>perioperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ergonomics of the Neuristim</measure>
    <time_frame>perioperatively</time_frame>
    <description>satisfaction questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech audiometry</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>in quiet and in noise</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pure tone audiometry</measure>
    <time_frame>3 months postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Hearing Loss, Cochlear</condition>
  <condition>Neurinoma of the Acoustic Nerve</condition>
  <arm_group>
    <arm_group_label>Neuristim</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electrical stimulation with the Neuristim and auditory nerve electrical response measurements (wave V).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Digisonic SP EVO cochlear implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Electrical stimulation with the patient's cochlear implant and auditory nerve electrical response measurements (wave V).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuristim</intervention_name>
    <description>Stimulation at high, medium and low intensity on apical, medial and basal Neuristim electrode</description>
    <arm_group_label>Neuristim</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cochlear implant</intervention_name>
    <description>Stimulation at high, medium and low intensity on apical, medial and basal Cochlear implant electrode</description>
    <arm_group_label>Digisonic SP EVO cochlear implant</arm_group_label>
    <other_name>Digisonic SP EVO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be 18 years or older

          -  Patient with an acoustic neuroma already surgically removed with associated hearing
             loss (experimental group),

          -  Patient with an acoustic neuroma programmed to be surgically removed and candidates
             for an implantable hearing rehabilitation solution (experimental group),

          -  Patient with an acoustic neuroma that not need to be removed and candidate for an
             implantable hearing rehabilitation solution (experimental group), or

          -  Typical patient candidate for a cochlear implant (control group)

        Exclusion Criteria:

          -  Cochlea malformation, cochlea ossification

          -  Vulnerable subject
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Vincent, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital University Lille-Roger Salengro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olivier Sterkers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital University Paris-La Pitié Salpétrière</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sébastien Schmerber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital University Grenoble-A. Michallon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Truy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Lyon-Edouard Herriot</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vincent Darrouzet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universiy Hospital Bordeaux-Pellegrin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dan Gnansia, PhD</last_name>
    <email>info-ic@oticonmedical.fr</email>
  </overall_contact>
  <link>
    <url>http://www.oticonmedical.com</url>
    <description>oticon medical website</description>
  </link>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2016</study_first_submitted>
  <study_first_submitted_qc>October 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2016</study_first_posted>
  <last_update_submitted>February 24, 2017</last_update_submitted>
  <last_update_submitted_qc>February 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Neuroma</mesh_term>
    <mesh_term>Neuroma, Acoustic</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

